FDA warns against purchase, consumption of unregistered turmeric, ginger powder

Marje Pelayo   •   March 12, 2019   •   3806

Turmeric powder| Photo by Simon A. Eugster on Wikimedia Commons

MANILA, Philippines – The Food and Drug Administration (FDA) warns the public against consumption of food products that were not registered and were not issued with proper authorization by the agency.

Specifically, the FDA advises consumers to be vigilant in purchasing ginger and turmeric powder or tea brands that are not checked by the agency in pursuant to R.A. 9711 or the Food and Drug Administration Act of 2009.

Some brands of ginger tea and turmeric powder that are banned by the FDA include:

  • Dollie’s Pure Turmeric Powder, Sugar Free
  • Dollie’s Pure Turmeric Tea (Bag)
  • IJ Turmeric Products Turmeric Instant Herbal Tea
  • Turmeric Fortified With 95% Curcumin C3 Complex Dietary Supplement
  • G Stuff Turmeric and Ginger Tea
  • G Stuff Amazing Tea
  • Reyes Turmeric Tea

Ginger root is known for its powerful medicinal benefits aside from being one of the favorite spices in the world.

Turmeric, a yellow-colored root also from the ginger family, is not only a popular spice in East India and Middle Eastern cuisines, it also boasts of anti-inflammatory agents as well as other properties that are helpful in curing several conditions such menstrual problems, hemorrhaging, toothaches, bruises, chest pain, flatulence, blood in the urine, among others.

Based on the FDA post-marketing surveillance (PMS) activities, these “unregistered food products have not gone through evaluation and testing process” and the agency “cannot guarantee their quality and safety.”

“Consumption of such violative products may pose potential health hazard to the consuming public,” the FDA said on its website.

The agency reminds consumers to be cautious in buying and consuming unregistered food products and urges the public to always check and verify product registration through the FDA website www.fda.gov.ph.

Meanwhile, concerned establishments are warned not to sell such violative food products until they get proper registration and authorization.

Regulatory actions and sanctions shall be strictly pursued against violators.

The agency also asked local government units (LGU) and law enforcement agencies “to ensure that these products are not sold or made available in their localities or areas of jurisdiction.”

List of other unregistered products banned by the FDA may be found on the agency’s official Facebook page https://www.facebook.com/FDAPhilippines/.

The public is further advised to report continuous sale or distribution of unregistered food products to www.fda.gov.ph/ereport, or send an e-mail to foodsafety@fda.gov.ph, or call the Center for Food Regulation and Research (CFRR) hotline (02) 857-1900 local 8115 and 8112. – Marje Pelayo

FDA warns public against purchase, use of ‘misbranded’ face masks

Robie de Guzman   •   August 6, 2020

MANILA, Philippines – The Food and Drug Administration (FDA) on Thursday warned healthcare professionals and the general public not to purchase and use face masks that are ‘misbranded’ and are sold in foreign characters.

In an advisory posted on Wednesday, the FDA identified the following misbranded face masks labeled in foreign characters:

  • Fu Le Bang disposable mask
  • Flag World Face Mask
  • Mask

The agency said that the mentioned medical device products are being offered for sale in the local market as verified through a post-marketing surveillance.

Republic Act 9711 or the FDA Act states that a device shall be deemed misbranded if any word, statement, or other information required to appear on the label is not appropriately placed or understandable to consumers.

The FDA said the manufacture, importation, exportation, sale, distribution, transfer, non-consumer use, promotion, advertising, or sponsorship of any misbranded health products is prohibited under the law.

The agency called on its regional field offices, law enforcement agencies and local government units to ensure that these products are not sold nor made available in the market or their areas of jurisdiction.

The FDA also urged the Bureau of Customs to restrain the entry of these misbranded products in the country.

23 out of 163 potential COVID-19 vaccines under clinical trial—FDA

Aileen Cerrudo   •   July 16, 2020

The Food and Drug Administration (FDA) said 23 out of 163 potential vaccines for coronavirus disease (COVID-19) are currently under clinical testing stage.

According to FDA Director General Eric Domingo, two potential COVID-19 vaccines will be given to a larger group of people to see if it is effective and to further evaluate its safety.

The said vaccines are Astrazeneca, currently being developed in London, and Sinovac that is being developed in China.

Department of Health (DOH) Spokesperson Usec. Maria Rosario Vergeire said that the anti-flu drug Favipiravir or Avigan, from Japan is also nearing clinical trials.

“We are fortunate that the Japanese have reached out to us to help increase the sample size of their Avigan drug trial, a potential treatment to prevent people from dying from COVID-19,” she said.

Meanwhile, the FDA has confirmed that another potential vaccine is being developed in Russia. Domingo said it is currently in the advanced phase.

“Ginagamit na rin siya sa clinical trial ng ibang bansa mayroon din sa Japan, China, United States, Italy at Russia, (It is currently under clinical trial in other countries like Japan, China, United States, and Russia),” he said.

The medicine for Ebola Virus, Remdesivir, is currently under solidarity trial. Remdesivir is being used in other countries to treat severe COVID-19 patients. AAC (with reports from Aiko Miguel)

FDA warns vs unsupervised use of Dexamethasone drug linked to COVID-19 treatment

Robie de Guzman   •   June 19, 2020

MANILA, Philippines – The Food and Drug Administration (FDA) on Friday warned the public against the use of steroid drug Dexamethasone without a prescription, following reports on its potential to treat novel coronavirus disease (COVID-19).

In an advisory, the FDA reminded the public that misuse or unsupervised chronic use of dexamethasone may lead to serious adverse reactions such as:

  • Immunosuppression or impairment of the body’s ability to fight infection
  • Gastrointestinal bleeding and ulcers
  • Electrolyte imbalance
  • Osteoporosis
  • Muscle weakness
  • Poor wound healing
  • Prolonged use of the drug may cause suppression of growth among infants and children
  • Obesity

If stopped abruptly, it may cause withdrawal symptoms such as hypotension, shock and coma.

“Dexamethasone is a steroid drug and is prescribed by a licensed physician based on the patient’s medical condition,” the FDA said.

“All are enjoined to report the dispense and/or use of the drug without a valid prescription to FDA Center for Drug Regulation and Research e-mail at cdrr.od@fda.gov.ph,” it added.

The agency also urged those using the drug to report any adverse reactions through this link.

The FDA warned that violators will be dealt with legal actions.

REACH US

The Philippine Broadcast Hub

UNTV, 915 Barangay Philam,

EDSA, Quezon City M.M. 1104

(+632) 8396-8688 (Tel)

info@untv-newsandrescue.com (General inquiries)

ABOUT UNTV

UNTV is a major TV broadcast network with 24-hour programming. An Ultra High Frequency station with strong brand content that appeal to everyone, UNTV is one of the most trusted and successful Philippine networks that guarantees wholesome and quality viewing experience.